147 related articles for article (PubMed ID: 16221392)
1. [Congenital heart block and autoantibodies].
Heegaard NH; Locht H; Wiik A
Ugeskr Laeger; 2005 Oct; 167(40):3775-6. PubMed ID: 16221392
[TBL] [Abstract][Full Text] [Related]
2. Outcome and growth of infants fetally exposed to heart block-associated maternal anti-Ro52/SSA autoantibodies.
Skog A; Wahren-Herlenius M; Sundström B; Bremme K; Sonesson SE
Pediatrics; 2008 Apr; 121(4):e803-9. PubMed ID: 18381509
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies against the serotoninergic 5-HT4 receptor and congenital heart block: a reassessment.
Kamel R; Eftekhari P; Clancy R; Buyon JP; Hoebeke J
J Autoimmun; 2005 Aug; 25(1):72-6. PubMed ID: 16009533
[TBL] [Abstract][Full Text] [Related]
4. Cloning and characterization of two human Ro52-specific monoclonal autoantibodies directed towards a domain associated with congenital heart block.
Salomonsson S; Ottosson L; Säfsten P; Hof D; Brauner H; Sunnerhagen M; Raats J; Wahren-Herlenius M
J Autoimmun; 2004 Mar; 22(2):167-77. PubMed ID: 14987746
[TBL] [Abstract][Full Text] [Related]
5. Ro/SSA autoantibodies directly bind cardiomyocytes, disturb calcium homeostasis, and mediate congenital heart block.
Salomonsson S; Sonesson SE; Ottosson L; Muhallab S; Olsson T; Sunnerhagen M; Kuchroo VK; Thorén P; Herlenius E; Wahren-Herlenius M
J Exp Med; 2005 Jan; 201(1):11-7. PubMed ID: 15630133
[TBL] [Abstract][Full Text] [Related]
6. Dying right to live longer: positing apoptosis as a link between maternal autoantibodies and congenital heart block.
Buyon JP; Clancy RM
Lupus; 2008 Feb; 17(2):86-90. PubMed ID: 18250129
[TBL] [Abstract][Full Text] [Related]
7. Connective-tissue disease, antibodies to ribonucleoprotein, and congenital heart block.
Scott JS; Maddison PJ; Taylor PV; Esscher E; Scott O; Skinner RP
N Engl J Med; 1983 Jul; 309(4):209-12. PubMed ID: 6866034
[TBL] [Abstract][Full Text] [Related]
8. Maternal autoantibodies and congenital heart block: clues from two consecutive pregnancies, one in which there was congenital complete heart block and one in which the fetus was healthy.
Horsfall AC; Neu E; Forrest G; Venables PJ; Field M
Arthritis Rheum; 1998 Nov; 41(11):2079-80. PubMed ID: 9811065
[No Abstract] [Full Text] [Related]
9. Maternal antibodies against fetal cardiac antigens in congenital complete heart block.
Taylor PV; Scott JS; Gerlis LM; Esscher E; Scott O
N Engl J Med; 1986 Sep; 315(11):667-72. PubMed ID: 3018560
[TBL] [Abstract][Full Text] [Related]
10. Anti-Ro52 monoclonal antibodies specific for amino acid 200-239, but not other Ro52 epitopes, induce congenital heart block in a rat model.
Ambrosi A; Dzikaite V; Park J; Strandberg L; Kuchroo VK; Herlenius E; Wahren-Herlenius M
Ann Rheum Dis; 2012 Mar; 71(3):448-54. PubMed ID: 22084395
[TBL] [Abstract][Full Text] [Related]
11. Maternal MHC regulates generation of pathogenic antibodies and fetal MHC-encoded genes determine susceptibility in congenital heart block.
Strandberg LS; Ambrosi A; Jagodic M; Dzikaite V; Janson P; Khademi M; Salomonsson S; Ottosson L; Klauninger R; Adén U; Sonesson SE; Sunnerhagen M; de Graaf KL; Kuchroo VK; Achour A; Winqvist O; Olsson T; Wahren-Herlenius M
J Immunol; 2010 Sep; 185(6):3574-82. PubMed ID: 20696861
[TBL] [Abstract][Full Text] [Related]
12. Congenital complete heart block and maternal anti-Ro.
Maclennan AC
Br J Hosp Med; 1990 Jul; 44(1):61. PubMed ID: 2397339
[No Abstract] [Full Text] [Related]
13. Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus.
Saleeb S; Copel J; Friedman D; Buyon JP
Arthritis Rheum; 1999 Nov; 42(11):2335-45. PubMed ID: 10555029
[TBL] [Abstract][Full Text] [Related]
14. [Autoantibodies as diagnostic markers in congenital heart block].
Dörner T; Göldner B; Yamamoto K; Apostoloff E; Hiepe F
Z Arztl Fortbild (Jena); 1994 Nov; 88(11):891-6. PubMed ID: 7839710
[No Abstract] [Full Text] [Related]
15. Immunohistologic evidence supports apoptosis, IgG deposition, and novel macrophage/fibroblast crosstalk in the pathologic cascade leading to congenital heart block.
Clancy RM; Kapur RP; Molad Y; Askanase AD; Buyon JP
Arthritis Rheum; 2004 Jan; 50(1):173-82. PubMed ID: 14730614
[TBL] [Abstract][Full Text] [Related]
16. Identification of discrete epitopes of Ro52p200 and association with fetal cardiac conduction system manifestations in a rodent model.
Hoxha A; Ruffatti A; Ambrosi A; Ottosson V; Hedlund M; Ottosson L; Anandapadamanaban M; Sunnerhagen M; Sonesson SE; Wahren-Herlenius M
Clin Exp Immunol; 2016 Dec; 186(3):284-291. PubMed ID: 27548532
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies associated with congenital heart block.
Salomonsson S; Strandberg L
Scand J Immunol; 2010 Sep; 72(3):185-8. PubMed ID: 20696014
[TBL] [Abstract][Full Text] [Related]
18. Serologic follow-up of children born to mothers with Ro/SSA autoantibodies.
Klauninger R; Skog A; Horvath L; Winqvist O; Edner A; Bremme K; Sonesson SE; Wahren-Herlenius M
Lupus; 2009 Aug; 18(9):792-8. PubMed ID: 19578103
[TBL] [Abstract][Full Text] [Related]
19. Prevention of complete heart block in children of mothers with anti-SSA/Ro and anti-SSB/La autoantibodies: detection and treatment of first-degree atrioventricular block.
Mevorach D; Elchalal U; Rein AJ
Curr Opin Rheumatol; 2009 Sep; 21(5):478-82. PubMed ID: 19584727
[TBL] [Abstract][Full Text] [Related]
20. Specificity and effector mechanisms of autoantibodies in congenital heart block.
Wahren-Herlenius M; Sonesson SE
Curr Opin Immunol; 2006 Dec; 18(6):690-6. PubMed ID: 17011766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
